![]()
- White House Plans to Freeze Spending to Cut Deficit
- Week Ahead: Investors Go for Quality, Assess Recovery
- Hedge Fund Billionaire Paulson Reports New Citi Stake
- Cramer: 5 Earnings Reports to Watch Next Week
- Court Rejects 'Clawbacks' for Alleged Stanford Victims
- Cities With the Most Home Price Reductions
- Tax Credit Sparking First-Time Home Sales: Realtors
- Investors Cut Back US Stocks for Bigger Growth Abroad
- This Year's Biggest Thanksgiving Leftover: Cash
- U.S. Stocks Rally for the Second Straight Week
- Dollar is Not Plunging—So 'Calm Down': Market Strategist
- Strategists Say Markets Have More Upside — But How Much?
- Hirschhorn: Risk-Averse Traders
- Roginsky: A Funny Thing Happened on the Way to Financial Reform
- This Year's Biggest Thanksgiving Leftover: Cash
- TV Series Inks Unique Deal For Fight
- First Time Buyers Rescue Housing: Realtors
- Dollar General Trades Higher After Its IPO
MOST SHARED
- CNBC Video: Warren Buffett & Bill Gates - Keeping American Great
- Today's Market Action
- Has Twitter's Finest Hours (Seconds) Come and Gone?
- Microsoft's Bill Gates Praises Apple's Steve Jobs For 'Saving the Company'
- CNBC TRANSCRIPT: Warren Buffett & Bill Gates - Keeping America Great
- China's Role as Lender Alters Dynamics for United States
- Israel Going Green
- Inside Wal-Mart's Acai Berry Juice Maker
- Low Interest Rate Investing
A federal judge has ruled that some product-liability claims against Boston Scientific over implantable heart defibrillators can proceed, rejecting the medical device maker's motions to dismiss them.
Guidant Corp., which Boston Scientific [BSX
Loading...
()
] bought last year, continued to sell heart rhythm-management devices after learning of possible defects, Judge Donovan Frank of the U.S. District Court in Minnesota said in a ruling Tuesday.
"This case concerns the issues of whether, how and to whom information was shared ... about a device with an alleged defect," Frank wrote in his ruling.
Boston Scientific, which bought Guidant to acquire its portfolio of heart devices, recalled more than 100,000 of the products between 2005 and 2006.
Guidant recalled more than 100,000 of its heart devices between 2005 and 2006.
"We are fully prepared to take the bellwether cases to trial and remain confident that when juries look into the individual facts, they will side with us," a Boston Scientific spokesman said. "Guidant defibrillators continue to be among the most reliable in the industry."
Boston Scientific, the No. 3 maker of the implantable heart devices after Medtronic Inc. and St. Jude Medical Inc. , has estimated damages and costs to cover legal expenses will be $732 million.
"Clearly, Boston Scientific knew they'd be facing litigation ... and in any litigation you're going to have wins and losses," said David Katz, chief investment officer at Matrix Asset Advisors, which owned 2.3 million Boston Scientific shares as of March 31, 2007. "You have to take them in stride."
Katz said the most important issues for the company over then next three to 12 months are progress in resolving a warning letter with the U.S. Food and Drug Administration, a turnaround in the markets for implantable cardioverter defibrillators, better known as ICDs, and drug-eluting stents, and cutting costs.
Michael Barr, an industry analyst with Victory Capital Management, added, "Boston Scientific definitely wants to get its debt levels down ... this is just one more thing that moves this company toward cost cutting."
Boston Scientific shares were down 5 cents to $16.00 in early New York Stock Exchange trade.
- Warren Buffett and Bill Gates spoke to Columbia students, and Buffett made the students a startling offer.
- For the chief of cable company Comcast, growth has been about making deals – generally very large deals.
- Some companies may start using insurance to shift carbon risk from their balance sheets to maybe... yours?
- The president and founder of Genesis Today wants to improve America’s health, and thinks Wal-Mart can help.
- Switzerland's privacy watchdog is taking legal action to force Google to make changes to its Street View service.
- A wealthy, distracted Texas driver crashed his million-dollar Bugatti Veyron sports car into a salt marsh, say police.













